AstraZeneca braced for hostile bid from Pfizer
Speculation is mounting that US pharmaceutical giant Pfizer is set to make a hostile bid for AstraZeneca after its €76bn takeover offer was spurned.
The UK company said the offer “substantially” undervalued the business, forcing Pfizer to consider its next move.
The Business Hub
Newsletter
News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.





